Mbb Se MBB ORD SHS/ DE000A0ETBQ4 /
24/05/2024 17:48:00 | Var. - | Volume | Denaro06:00:05 | Lettera06:00:05 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
110.47EUR | - | 581 Fatturato: 63,710.20 |
-Quantità in denaro: - | -Quantità in lettera: - | 657.26 mill.EUR | 1.78% | - |
GlobeNewswire
13:05
Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at t...
GlobeNewswire
13:03
Velocity Clinical Research partners with Luminis Health, moves into oncology in the U.S.
GlobeNewswire
13:00
Taysha Gene Therapies to Present Clinical Data from Both REVEAL Phase 1/2 Trials During Company-Host...
GlobeNewswire
13:00
Athira to Host Webinar Highlighting Potential for Fosgonimeton to Protect and Preserve Neuronal Heal...
GlobeNewswire
13:00
United Lithium Announces Drill Results for Lithium Pegmatites D & E Confirming Strike Length of over...
GlobeNewswire
13:00
Dorman Products announces the grand opening of an additional USA-based drive shaft manufacturing fac...
GlobeNewswire
13:00
Ero Copper's Tucumã Project Awarded Operational License - Commissioning On Track for First Copper Pr...
GlobeNewswire
13:00
Dianthus Therapeutics Announces FDA Clearance to Initiate Phase 2 Trial of DNTH103 in Multifocal Mot...
GlobeNewswire
13:00
Embrace the Spirit of Summer and Create Shareable Moments with Good Supply Cannabis
GlobeNewswire
13:00
2024 Report: LGBTQ+ Advertising Influential Over Brand Perceptions & Purchase Decisions
GlobeNewswire
13:00
KSQ Therapeutics Announces First Patient Dosed in Clinical Development Program for KSQ-001EX, a CRIS...
GlobeNewswire
13:00
Bread Financial™ Signs Long-Term Agreement to Provide Dual Credit Card Program for Saks Fifth Avenue...
GlobeNewswire
13:00
NodThera’s NLRP3 Inhibitor NT-0796 Meets Primary Endpoint of Inflammation Reversal in Phase Ib/IIa T...
GlobeNewswire
12:58
RentRedi and Home Title Lock Partner to Protect Rental Property Owners from Deed Fraud and Title The...